doi: 10.3390/ijms23010280 184 MatthayM
Glucagon-like peptide agonists (GLP-1) drugs were originally approved to help manage Type 2 diabetes (T2D) and are now also being prescribed and used for weight management
Figure 3 3.1 Inhibition of oxidative stress An imbalance between pro-oxidants and antioxidants can result in tissue and organ damage, known as oxidative stress. This imbalance may arise from excessive production of ROS or deficiencies in the antioxidant defence mechanisms (14)
Edo GI et al
DAgostino, I., Tacconelli, S., Bruno, A., Contursi, A., Mucci, L., Hu, X., Xie, Y., Chakraborty, R., Jain, K., Sacco, A., Zucchelli, M., Landolfi, R., Dovizio, M., Falcone, L., Ballerini, P., Hwa, J., & Patrignani, P